{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T01:40:17Z","timestamp":1790991617306,"version":"4.1.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Res Notes"],"published-print":{"date-parts":[[2013,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Epilepsy is a common health problem which carries a huge medical social psychological and economic impact for a developing country. The aim of this hospital-based study was to get an insight into the effectiveness and tolerability of low cost antiepileptic drugs (AEDs) in Bangladeshi people with epilepsy.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>This retrospective chart review was done from hospital records in weekly Epilepsy outdoor clinic of Department of Neurology, Dhaka Medical College Hospital (DMCH) from October 1998 to February 2013. A total of 854 epilepsy patients met the eligibility criteria (had a complete record of two years of follow up data) from hospital database. A checklist was used to take demographics (age and gender), epilepsy treatment and adverse event related data. At least two years of follow up data were considered for analysis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Out of 854 patients selected, majority of the patients attending outdoor clinic were &gt;11-30 years age group (55.2%) with a mean age of 20.3 \u00b1 9 years and with a male (53%) predominance. Focal epilepsy were more common (53%), among whom secondary generalized epilepsy was the most frequent diagnosis (67%) followed by complex partial seizure (21%). Among those with Idiopathic Generalized Epilepsy (46%), generalized tonic clonic seizure was encountered in 74% and absence seizure was observed in 13%. The number of patients on monotherapy and dual AED therapy were 67% and 24% respectively and polytherapy (i.e. &gt;3 AEDs) was used only in 9%. CBZ (67%) was the most frequently prescribed AED, followed by VPA (43%), PHB (17%), and PHT (8%). CBZ was prescribed in 37% patients as monotherapy followed by VPA in 21% and PHB in 8% patients. Newer generation drugs eg lemotrigine and topiramate were used only as add on therapy in combination with CBZ and VPA in only 2% patients. The treatment retention rates over the follow up period for the AEDs in monotherapy varied between 86 and 91% and were highest for CBZ, followed by VPA. Most of the combination regimens had a treatment retention rate of 100%. The effectiveness of AED in terms of reduction of seizure frequency was highest for PHT (100%) and PHB (98%) followed by CBZ (96%) and VPA (95%). PHB and PHT were the cheapest of all AEDs (42 I$ and 56 I$\/ year respectively). The costs of VPA and CBZ were two times and LTG and TOP were six to eight times higher. Adverse drug reaction (ADR) were observed among 140 (24.5%) of those with monotherapy. PHT (64%) was the most common drug to cause ADR, CBZ was at the bottom of the list to cause adverse effect (11.6%). VPA and PHB caused weight gain commonly. Adjustment of drug dose or withdrawal due to ADRs was necessary in 39% with PHT and 26% with PHB.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Though PHT and PHB are cheapest and efficacious among all, CBZ and VPA are less costly, effective and well tolerated drug for seizure control in context of Bangladesh.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1756-0500-6-473","type":"journal-article","created":{"date-parts":[[2013,11,19]],"date-time":"2013-11-19T02:21:48Z","timestamp":1384827708000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Antiepileptic drug utilization in Bangladesh: experience from Dhaka Medical College Hospital"],"prefix":"10.1186","volume":"6","author":[{"given":"Mansur","family":"Habib","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharif Uddin","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md Azhahul","family":"Hoque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md Badrul Alam","family":"Mondal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ATM Hasibul","family":"Hasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajib Nayan","family":"Chowdhury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Badrul","family":"Haque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazi Mohibur","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed Hossain","family":"Chowdhury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swapon Kumar","family":"Ghose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quazi Deen","family":"Mohammad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,11,18]]},"reference":[{"key":"2494_CR1","unstructured":"How Common is Epilepsy in South-East Asia? Some facts and figures on Epilepsy. Avaialable at: http:\/\/tinyurl.com\/ngcl4bd"},{"key":"2494_CR2","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1212\/WNL.0b013e31822cfc90","volume":"77","author":"AK Ngugi","year":"2011","unstructured":"Ngugi AK, Kariuki SM, Bottomley C, et al: Incidence of epilepsy: a systemic review and meta-analysis. Neurology. 2011, 77: 1005-1011. 10.1212\/WNL.0b013e31822cfc90.","journal-title":"Neurology"},{"key":"2494_CR3","volume-title":"Epilepsy: epidemiology, aetiology and prognosis","author":"World Health Organization","year":"2001","unstructured":"World Health Organization: Epilepsy: epidemiology, aetiology and prognosis. 2001, WHO fact sheet, Available at: http:\/\/www.who.int\/inf-fs\/en\/fact165.html."},{"issue":"suppl 4","key":"2494_CR4","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/j.1468-1331.2005.01326.x","volume":"12","author":"JW Sander","year":"2005","unstructured":"Sander JW: Ultimate success in epilepsy: the patient\u2019s perspective. Eur J Neurol. 2005, 12 (suppl 4): 3-11.","journal-title":"Eur J Neurol"},{"key":"2494_CR5","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1111\/j.1528-1157.1996.tb00006.x","volume":"37","author":"A Jacoby","year":"1996","unstructured":"Jacoby A, Baker GA, Steen N, Potts P, Chadwick DW: The clinical course of epilepsy and its psychosocial correlates: findings from a UK community study. Epilepsia. 1996, 37: 148-161. 10.1111\/j.1528-1157.1996.tb00006.x.","journal-title":"Epilepsia"},{"key":"2494_CR6","volume-title":"Response to first drug treatment may signal likelihood of future seizures in people with epilepsy","author":"P Kwan","year":"2012","unstructured":"Kwan P, American Academy of Neurology (AAN): Response to first drug treatment may signal likelihood of future seizures in people with epilepsy. 2012, Available at: http:\/\/www.aan.com\/PressRoom\/Home\/PressRelease\/1073"},{"key":"2494_CR7","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1056\/NEJM199601183340308","volume":"334","author":"MJ Brodie","year":"1996","unstructured":"Brodie MJ, Dichter MA: Antiepileptic drugs. N Engl J Med. 1996, 334: 168-175. 10.1056\/NEJM199601183340308.","journal-title":"N Engl J Med"},{"key":"2494_CR8","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.arcmed.2004.11.006","volume":"36","author":"D Deleu","year":"2005","unstructured":"Deleu D, Aarons L, Ahmed IA: Estimation of population pharmacokinetic parameters of free-phenytoin in adult people with epilepsy. Arch Med Res. 2005, 36: 49-53. 10.1016\/j.arcmed.2004.11.006. Erratum: Arch Med Res 2005;36:49\u201353. Erratum","journal-title":"Arch Med Res"},{"key":"2494_CR9","volume-title":"CHOosing Interventions that are Cost Effective (WHO-CHOICE)","author":"Purchasing Power Parity","year":"2005","unstructured":"Purchasing Power Parity: CHOosing Interventions that are Cost Effective (WHO-CHOICE). 2005,http:\/\/www.who.int\/choice\/costs\/ppp\/en\/,"},{"issue":"3","key":"2494_CR10","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1136\/jnnp.57.3.320","volume":"57","author":"M Placencia","year":"1994","unstructured":"Placencia M, et al: The characteristics of epilepsy in a largely untreated population in rural Ecuador. J Neurol Neurosurg Psychiatry. 1994, 57 (3): 320-325. 10.1136\/jnnp.57.3.320.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2494_CR11","volume-title":"Geneva, World Health Organization, 2000 Information Pack for the launch of the Global Campaign\u2019s Second Phase, 12\u201313","author":"The Global Campaign Against Epilepsy","year":"2001","unstructured":"The Global Campaign Against Epilepsy: Geneva, World Health Organization, 2000 Information Pack for the launch of the Global Campaign\u2019s Second Phase, 12\u201313. 2001, Geneva: World Health Organization"},{"key":"2494_CR12","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1111\/j.1528-1157.2000.tb00166.x","volume":"41","author":"CE Begley","year":"2000","unstructured":"Begley CE, Famular A, Annegers JF, et al: The cost of epilepsy in the United States: an estimate from population-based and survey data. Epilepsia. 2000, 41: 342-352. 10.1111\/j.1528-1157.2000.tb00166.x.","journal-title":"Epilepsia"},{"key":"2494_CR13","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/0920-1211(94)90045-0","volume":"18","author":"OC Cockerell","year":"1994","unstructured":"Cockerell OC, Hart YM, Sander JWAS, et al: The cost of epilepsy in the United Kingdom: an estimation based on the results of two population-based studies. Epilepsy Res. 1994, 18: 249-260. 10.1016\/0920-1211(94)90045-0.","journal-title":"Epilepsy Res"},{"key":"2494_CR14","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1046\/j.1528-1157.2001.0420081052.x","volume":"42","author":"SV Thomas","year":"2001","unstructured":"Thomas SV, Sarma PS, Alexander M, et al: Economic burden of epilepsy in India: Epilepsia. Epilepsia. 2001, 42: 1052-1060. 10.1046\/j.1528-1157.2001.0420081052.x.","journal-title":"Epilepsia"},{"issue":"1","key":"2494_CR15","first-page":"18","volume":"9","author":"MA Mannan","year":"2004","unstructured":"Mannan MA: Epilepsy in Bangladesh. Neurol Asia. 2004, 9 (1): 18-","journal-title":"Neurol Asia"},{"key":"2494_CR16","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/S1474-4422(07)70127-8","volume":"6","author":"TL Mac","year":"2007","unstructured":"Mac TL, Tran DS, Quet F, Odermatt P, Preux PM, Tan CT: Epidemiology, aetiology, and clinical management of epilepsy in Asia: a systematic review. Lancet Neurol. 2007, 6: 533-543. 10.1016\/S1474-4422(07)70127-8.","journal-title":"Lancet Neurol"},{"key":"2494_CR17","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1001\/archneur.55.7.1019","volume":"55","author":"BS Singhal","year":"1998","unstructured":"Singhal BS: Neurology in developing countries: apopulation perspective. Arch Neurol. 1998, 55: 1019-1021. 10.1001\/archneur.55.7.1019.","journal-title":"Arch Neurol"},{"key":"2494_CR18","first-page":"252","volume":"9","author":"GCY Fong","year":"2003","unstructured":"Fong GCY, Mak W, Cheng TS: A prevalence study of epilepsy in Hong Kong. Hong Kong Med J. 2003, 9: 252-257.","journal-title":"Hong Kong Med J"},{"key":"2494_CR19","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1111\/j.1528-1157.2000.tb00289.x","volume":"41","author":"K Radhakrishnan","year":"2000","unstructured":"Radhakrishnan K, Pandian JD, Santhoshkuma T, et al: Prevalence, knowledge, attitude and practice of epilepsy in Kerala, South India. Epilepsia. 2000, 41: 1027-1035. 10.1111\/j.1528-1157.2000.tb00289.x.","journal-title":"Epilepsia"},{"key":"2494_CR20","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1159\/000092407","volume":"26","author":"DS Tran","year":"2006","unstructured":"Tran DS, Odermatt P, Le TO, et al: Prevalence of epilepsy in a rural district of central Lao PDR. Neuroepidemiology. 2006, 26: 199-206. 10.1159\/000092407.","journal-title":"Neuroepidemiology"},{"key":"2494_CR21","first-page":"471","volume":"26","author":"NK Loh","year":"1997","unstructured":"Loh NK, Lee WL, Yew WW, et al: Refractory seizures in a young army cohort. Ann Acad Med Singap. 1997, 26: 471-474.","journal-title":"Ann Acad Med Singap"},{"key":"2494_CR22","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/S0887-8994(01)00247-8","volume":"24","author":"KL Kwong","year":"2001","unstructured":"Kwong KL, Chak WK, Wong SN, et al: Epidemiology of childhood epilepsy in a cohort of 309 Chinese children. Pediatr Neurol. 2001, 24: 276-282. 10.1016\/S0887-8994(01)00247-8.","journal-title":"Pediatr Neurol"},{"issue":"5","key":"2494_CR23","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1111\/j.1528-1157.1993.tb02095.x","volume":"34","author":"N Senanayake","year":"1993","unstructured":"Senanayake N: Classification of epileptic seizures: a hospital-based study of 1,250 patients in a developing country. Epilepsia. 1993, 34 (5): 812-818. 10.1111\/j.1528-1157.1993.tb02095.x.","journal-title":"Epilepsia"},{"key":"2494_CR24","first-page":"781","volume-title":"Comprehensive epileptology","author":"KS Mani","year":"1990","unstructured":"Mani KS, Rangan G: Epilepsy in the Third World-Asian aspects. Comprehensive epileptology. Edited by: Dam M, Gram L. 1990, New York: Raven Press, 781-793."},{"key":"2494_CR25","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1111\/j.1528-1157.1985.tb05393.x","volume":"26","author":"Commission on Tropical Diseases of the International League Against Epilepsy","year":"1985","unstructured":"Commission on Tropical Diseases of the International League Against Epilepsy: Availability and distribution of antiepileptic drugs in developing countries. Epilepsia. 1985, 26: 117-121.","journal-title":"Epilepsia"},{"key":"2494_CR26","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.0013-9580.2004.63102.x","volume":"45","author":"A Krishnan","year":"2004","unstructured":"Krishnan A, Sahariah SU, Kumar KS: Cost of epilepsy in patients attending a secondary-level hospital in India. Epilepsia. 2004, 45: 289-291. 10.1111\/j.0013-9580.2004.63102.x.","journal-title":"Epilepsia"},{"issue":"suppl 1","key":"2494_CR27","first-page":"16","volume":"9","author":"D Gunawan","year":"2004","unstructured":"Gunawan D: Epilepsy management with limited resources. Indonesian experience. Neurol Asia. 2004, 9 (suppl 1): 16-17.","journal-title":"Neurol Asia"},{"key":"2494_CR28","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1053\/seiz.2001.0579","volume":"11","author":"U Seneviratne","year":"2002","unstructured":"Seneviratne U, Rajapakse P, Pathirana R, et al: Knowledge, attitude, and practice of epilepsy in rural Sri Lanka. Seizure. 2002, 11: 40-43. 10.1053\/seiz.2001.0579.","journal-title":"Seizure"},{"key":"2494_CR29","first-page":"233","volume":"52","author":"SH Kariyawasam","year":"2004","unstructured":"Kariyawasam SH, Bandara N, Koralagama A, et al: Challenging epilepsy with antiepileptic pharmacotherapy in a tertiary teaching hospital in Sri Lanka. Neurol India. 2004, 52: 233-237.","journal-title":"Neurol India"},{"key":"2494_CR30","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/S1059-1311(03)00006-2","volume":"12","author":"L Lillian","year":"2003","unstructured":"Lillian L, Chun-Hing Y, Der-Jen Y, et al: Medication education for patients with epilepsy in Taiwan. Seizure. 2003, 12: 473-477. 10.1016\/S1059-1311(03)00006-2.","journal-title":"Seizure"},{"key":"2494_CR31","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1016\/S0140-6736(76)92709-4","volume":"1","author":"EH Reynolds","year":"1976","unstructured":"Reynolds EH, Chadwick DW, Shorvon SD: One drug (phenytoin) for treatment of epilepsy. Lancet. 1976, 1: 923-926.","journal-title":"Lancet"},{"key":"2494_CR32","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1136\/bmj.1.6077.1635","volume":"1","author":"SD Shorvon","year":"1977","unstructured":"Shorvon SD, Reynolds EH: Unnecessary polypharmacy for epilepsy. BMJ. 1977, 1: 1635-1637. 10.1136\/bmj.1.6077.1635.","journal-title":"BMJ"},{"key":"2494_CR33","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1136\/bmj.2.6197.1023","volume":"2","author":"SD Shorvon","year":"1979","unstructured":"Shorvon SD, Chadwick DW, Galbraith AW, et al: One drug for epilepsy. BMJ. 1979, 2: 1023-1025. 10.1136\/bmj.2.6197.1023.","journal-title":"BMJ"},{"key":"2494_CR34","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1046\/j.1365-2710.2002.00429.x","volume":"27","author":"Y Hanssens","year":"2002","unstructured":"Hanssens Y, Deleu D, Al Balushi K, Al Hashar A, Al-Zakwani I: Drug utilization pattern of anti-epileptic drugs: a pharmacoepidemiologic study in Oman. J Clin Pharm Ther. 2002, 27: 357-364. 10.1046\/j.1365-2710.2002.00429.x.","journal-title":"J Clin Pharm Ther"},{"key":"2494_CR35","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1056\/NEJM198507183130303","volume":"313","author":"RH Mattson","year":"1985","unstructured":"Mattson RH, Cramer JA, Collins JF, Smith DB, Delgado-Escueta AV, Browne TR, et al: Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondarily generalized tonic-clonic seizures. N Engl J Med. 1985, 313: 145-151. 10.1056\/NEJM198507183130303.","journal-title":"N Engl J Med"},{"key":"2494_CR36","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1111\/j.1528-1157.1993.tb02126.x","volume":"34","author":"JW Sander","year":"1993","unstructured":"Sander JW: Some aspects of prognosis in the epilepsies: a review. Epilepsia. 1993, 34: 1007-1016. 10.1111\/j.1528-1157.1993.tb02126.x.","journal-title":"Epilepsia"},{"key":"2494_CR37","volume-title":"The Cochrane Library","author":"A Marson","year":"2004","unstructured":"Marson A, Williamson P, Hutton J, Clough H, Chadwick D: Carbamazepine versus valproate monotherapy for epilepsy (Cochrane Review), Volume 1. The Cochrane Library. 2004, Chichester, UK: John Wiley & Sons Ltd"},{"issue":"Suppl 9","key":"2494_CR38","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1111\/j.1528-1157.1997.tb05199.x","volume":"38","author":"D Chadwick","year":"1997","unstructured":"Chadwick D: Monotherapy clinical trials of new antiepileptic drugs: design, indications, and controversies. Epilepsia. 1997, 38 (Suppl 9): 16-20.","journal-title":"Epilepsia"},{"key":"2494_CR39","first-page":"44","volume":"79","author":"RA Scott","year":"2001","unstructured":"Scott RA, Lhatoo SD, Sander JW: The treatment of epilepsy in developing countries: where do we go from here?. Bull World Health Organ. 2001, 79: 44-351.","journal-title":"Bull World Health Organ"},{"key":"2494_CR40","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1002\/9780470752463.ch39","volume-title":"The treatment of epilepsy","author":"R Michelucci","year":"2004","unstructured":"Michelucci R, Tassinari CA: Phenobarbital, primidone and other barbiturates. The treatment of epilepsy. Edited by: Shorvon S, Perucca E, Fish D, Dodson E. 2004, Oxford: Blackwell, 461-474. 2","edition":"2"},{"key":"2494_CR41","doi-asserted-by":"publisher","first-page":"378","DOI":"10.2165\/00002018-199615060-00003","volume":"15","author":"SJ Wallace","year":"1996","unstructured":"Wallace SJ: A comparative review of the adverse effects of anticonvulsants in children with epilepsy. Drug Saf. 1996, 15: 378-393. 10.2165\/00002018-199615060-00003.","journal-title":"Drug Saf"},{"key":"2494_CR42","volume-title":"BMJ","author":"SH Banu","year":"2007","unstructured":"Banu SH, Jahan M, Koli UK, Ferdousi S, Khan NZ, Neville B: Side effects of phenobarbital and carbamazepine in childhood epilepsy: randomised controlled trial. BMJ. 2007, doi:10.1136\/bmj.39022.436389.BE"},{"key":"2494_CR43","doi-asserted-by":"publisher","first-page":"148","DOI":"10.2165\/00023210-199606020-00006","volume":"6","author":"P Loiseau","year":"1996","unstructured":"Loiseau P: Tolerability of newer and older anticonvulsants: a comparative review. CNS Drugs. 1996, 6: 148-166. 10.2165\/00023210-199606020-00006.","journal-title":"CNS Drugs"},{"issue":"1","key":"2494_CR44","first-page":"55","volume":"3","author":"S Mathur","year":"2010","unstructured":"Mathur S, Sen S, Ramesh L, Kumar SM: Utilization pattern of antiepileptic drugs and their adverse effects, in a teaching hospital. Asian J Pharm Clin Res. 2010, 3 (1): 55-59.","journal-title":"Asian J Pharm Clin Res"},{"key":"2494_CR45","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1002\/pds.1540","volume":"17","author":"B Roopa","year":"2008","unstructured":"Roopa B, Sujatha S, Narayan MD, et al: Pattern of adverse drug reactions to anti-epileptic drugs: a cross-sectional one-year survey at a tertiary care hospital. Pharmacoepidemiol Drug Saf. 2008, 17: 807-812. 10.1002\/pds.1540.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2494_CR46","doi-asserted-by":"publisher","first-page":"16","DOI":"10.4103\/1817-1745.40586","volume":"3","author":"JD Desai","year":"2008","unstructured":"Desai JD: Epilepsy and cognition. J Pediatr Neurosci. 2008, 3: 16-29. 10.4103\/1817-1745.40586.","journal-title":"J Pediatr Neurosci"},{"key":"2494_CR47","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.seizure.2005.01.008","volume":"14","author":"JA Carpay","year":"2005","unstructured":"Carpay JA, Aldencamp CA, Donselaar V: Complaints associated with the use of antiepileptic drugs: results from a community-based study. Seizure. 2005, 14: 198-206. 10.1016\/j.seizure.2005.01.008.","journal-title":"Seizure"},{"key":"2494_CR48","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1212\/WNL.56.2.172","volume":"56","author":"V Biton","year":"2001","unstructured":"Biton V, Mirza W, Montouris G, Vuong A, Hammer AE, Barrett PS: Weight change associated with valproate and lamotrigine monotherapy in patients with epilepsy. Neurology. 2001, 56: 172-177. 10.1212\/WNL.56.2.172.","journal-title":"Neurology"},{"key":"2494_CR49","volume-title":"Improving the Lives of People with One of the Nation\u2019s Most Common Neurological Conditions At A Glance","author":"Targeting Epilepsy","year":"2011","unstructured":"Targeting Epilepsy: Improving the Lives of People with One of the Nation\u2019s Most Common Neurological Conditions At A Glance. 2011, Centers for Disease Control and Prevention National Center for Chronic Disease Prevention and Health Promotion (NCCDPHP), Available at: http:\/\/www.cdc.gov\/chronicdisease\/resources\/publications\/aag\/epilepsy.htm"},{"key":"2494_CR50","first-page":"1","volume-title":"Biomed Central","author":"R Hutubessy","year":"2003","unstructured":"Hutubessy R, Chisholm D, Torres TT: Generalized cost effectiveness analysis for national level priority-setting in the health sector: cost effectiveness and resource allocation. Biomed Central. 2003, 1-8. Available at: http:\/\/www.resourceallocation.com\/content\/1\/December\/2003"}],"container-title":["BMC Research Notes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1756-0500-6-473.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T02:18:41Z","timestamp":1630549121000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcresnotes.biomedcentral.com\/articles\/10.1186\/1756-0500-6-473"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11,18]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["2494"],"URL":"https:\/\/doi.org\/10.1186\/1756-0500-6-473","relation":{},"ISSN":["1756-0500"],"issn-type":[{"value":"1756-0500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,11,18]]},"assertion":[{"value":"6 August 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2013","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"473"}}